OBJECTIVES: Minimally invasive techniques seem to be promising alternatives to open approaches in the surgical treatment of early-stage thymoma, although there are controversies because of lack of data on long-term results. The aim of the study was to evaluate the surgical and oncological results after robotic thymectomy for early-stage thymoma compared to median sternotomy.
Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study † 
INTRODUCTION
Thymomas are rare neoplasms, representing 0.2-1.5% of all malignancies, but are the most common tumours of the mediastinum [1] . Surgery is the cornerstone of treatment, particularly for early-stage disease, and completeness of resection with adequate safety margins is the main prognostic factor [2] . Different surgical approaches have been described to perform thymectomy, but to date, sternotomy still represents the gold standard. Minimally invasive approaches seem to be promising alternatives to open techniques and, in the last 2 decades, have been slowly adopted in the surgery of malignant tumours of the mediastinal district. The main downsides are the supposed increased risk of local recurrence (due to reduced safety margins after minimally invasive resection) and the possible rupture of the capsule with implantation of the tumour during endoscopic manipulations. Furthermore, the lack of long-term oncological results, the learning curve required to perform this operation safely and the relative rarity of these tumours are additional reasons that slow down the diffusion of the video-assisted thoracic surgery (VATS) resection [3] [4] [5] . The introduction of robotic-assisted technologies in the late 1990s provided a technical advancement able to overcome the limitations of conventional thoracoscopy: the three-dimensional vision system and the articulated instruments of the daVinci Surgical Robotic System (Intuitive Surgical, Inc., Sunnyvale, CA, USA) allow for an 'open-like' intervention with a minimally invasive access. The application of robotic technology has been tested in a variety of thoracic surgery procedures, with a prevalent application for mediastinal diseases, where the robotic system seems to provide the best advantages [6, 7] .
The aim of the study was to evaluate the surgical and oncological results after robotic thymectomy (RATS) for early-stage thymoma, compared with a population of patients operated on through a median sternotomy.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of 278 patients with a thymic tumour who underwent surgical resection in the Unit of Thoracic Surgery of the University of Padova, from June 1982 to December 2016. Exclusion criteria were thymic neoplastic diseases other than thymoma, advanced stage disease (Stage III or IV according to Masaoka), incomplete resection (R1 or R2) and surgical resection other than trans-sternal or robotic technique. One hundred and sixty-four patients who met the inclusion criteria (Stage I or II thymoma completely surgically resected using either the trans-sternal or the robotic approach) were selected for the study. The institutional review board approved this study.
All patients signed a detailed consent form in which they were informed about the possible complications of thymoma resection by the robotic approach and the lack of long-term data.
Information on patient demographics, presence of associated myasthenia gravis (MG), tumour characteristics, stage, intraoperative and postoperative data (e.g. complications, need for open conversion or additional ports or accesses, operative time, day of drain removal and length of hospital stay), total cost of operation and postoperative stay and administration of adjuvant treatment were collected.
The Masaoka staging system [8] was used to assess the pathological stage, and the new World Health Organization classification was used to define the histology [9] .
Preoperative assessments included an evaluation of pulmonary and cardiac functions together with a total body computed tomography or magnetic resonance imaging. Preferred radiological characteristics to be eligible for RATS were the following: location of the tumour in the anterior mediastinum; distinct fat plane between the tumour and surrounding structures; unilateral tumour predominance; tumour encapsulation; existence of residual, normal-appearing thymic tissue and no mass compression effect. Although the tumour size was not considered a strict selection criterion for the robotic approach, a tumour diameter < _5 cm was preferred. Exclusion criteria for robotic surgery were radiological evidence of invasion of the surrounding structures (e.g. pericardium, lung, nerves or large vessels), the presence of adhesions (e.g. previous thoracic surgery or pleuritis), the inability to perform single-lung ventilation and a body mass index >35 kg/m 2 . All patients completed the follow-up (the last follow-up was May 2017) with a periodic clinical evaluation. Chest and abdominal computed tomographic scans were required every 6 months during the first 2 years after surgery and then every year.
Robotic surgical technique
The side of surgical access was based on the presence of unilateral tumour predominance. The RATS surgical technique from either the left or the right side has been described previously [10, 11] . We emphasize some technical tips and pitfalls. A monopolar cautery spatula was used routinely for dissection, focusing on avoiding thermal injury particularly when operating close to the phrenic nerves. Carbon dioxide insufflation of 6-10 mmHg was applied during the procedure to increase the size of the mediastinal space. All surgeons involved in the procedure adopted a 'no-touch technique' with an en bloc resection of the thymus and perithymic fat tissue. During the application of this technique, the thymoma was never touched, and normal thymic tissue and perithymic fat were used for grasping and for traction, so as to avoid direct manipulation of the tumour, capsular damage and potential seeding. All thymic and perithymic fat was dissected together with thymoma with safe surgical margins, in agreement with the International Thymic Malignancy Interest Group (ITMIG) criteria [12] . In case of myasthenic patients, particular attention was posed on the removal of all the mediastinal fat.
Cost analysis
We analysed both the operation and the hospital stay costs. According to the data of the Ministry of Economy, the average daily cost for a hospital in Italy is 674e per patient. Regarding the cost of the operation, because the fixed cost of the surgical theatre, the healthcare personal cost and the anaesthetics cost could be considered equal in both operations, we considered only the expense for specific materials used in each operation. Performing a trans-sternal thymectomy requires the use of stainless steel wires for the closure of the sternotomy, and these cost around 150e per patient (data from the centre's finance group). Conversely, for a RATS, at least the following instruments are needed (cost in parenthesis): CADIERE forceps (4509e), monopolar cautery spatula (4501e) and Robotic 100 clips applier (4723e). However, due to the fact that these instruments can be used for 10 operations, for a single operation, the overall price should be divided by 10, resulting in 1373e per patient.
Statistical analysis
Continuous data are expressed as mean and standard deviation, whereas categorical variables are expressed as counts and percentages. The normality of the quantitative variable distribution was verified by the Shapiro-Wilk test. At first step, the statistical analyses were performed to compare the characteristics of the trans-sternal thymectomy (TST) and RATS groups. The Student's t-test for unpaired data or Wilcoxon's summed rank test were used, as appropriate, to evaluate differences between means.
At second step, the propensity score matching was based on 5 variables [age at surgery, Masaoka stage, World Health Organization (WHO) histological classification, tumour dimension and MG] that resulted significantly associated with the surgical group at logistic regression analysis. The matching process used the nearest neighbour method. To take into account a possible selection bias due to surgery period, the matched patients were compared using generalized linear models adjusting for year of surgery. A P-value <0.05 was considered to indicate statistical significance. Statistical analyses and matching were performed using R packages from the Comprehensive R Archive Network.
RESULTS
Of the 164 patients selected for this study, 108 (66%) patients underwent TST and 56 (34%) patients RATS. The baseline patient and tumour characteristics in the 2 groups are presented in Table 1 . Compared with the TST group, the RATS group was characterized by a younger age, a higher percentage of MG, a lower diameter of the tumour and a higher proportion of Masaoka Stage II thymoma.
The surgical outcome in the RATS and TST groups are presented in Table 2 . In the RATS group, 6 patients were approached from the right thoracic cavity and 50 patients from the left side.
No intraoperative or perioperative mortality was recorded for both groups. Two (3%) patients in the minimally invasive group needed open conversion, in 1 case because of the dimension of the specimen and difficult dissection (myasthenic patient with abundant mediastinal fat) and in the other because of suspicions of pericardial infiltration. In 1 patient, a cervicotomy was performed to complete the dissection of the thymus in the neck.
Regardless of the surgical approach, all patients had an R0 resection, and there were no intraoperative deaths.
In the RATS group, the median operative time (skin-to-skin, comprehensive of operative time at the console, docking, specimen removal and undocking) was 132.5 min [interquartile range (IQR) 115.0-170.0 min], and in the TST group, it was significantly shorter (median 115.0 min, IQR 90.0-137.5 min; P < 0.001).
The robotic group had significantly less intraoperative blood loss [when the cut-off is set at 100 ml (P = 0.02), while the significance was lost at a cut-off of 200 ml (P = 0.13)] and earlier chest drain removal and hospital discharge.
The overall incidence of perioperative complications was higher in the TST group than in the RATS group (15% vs 4%; P = 0.03); however, no significant difference was reached for major complications (P = 0.72). Seven patients in the TST group had the following major complications: 3 respiratory failures, 2 myasthenic crisis, 1 sternal dehiscence and 1 cardiac arrest. Two patients in the RATS group presented with each one of the following complications: myasthenic crisis and haemothorax, which required surgical treatment. The median expense for a TST and consequent hospital stay was e4194 (IQR e3520-e4868), which was significantly higher than the cost for a RATS (e3395, IQR e3395-e4069, P < 0.001).
Sixty-four patients received postoperative radiotherapy, 25 (45%) in the robotic group and 39 (36%) in the trans-sternal group, with no significant difference between groups (P = 0.30).
Two (2%) patients in the TST group had a thymoma recurrence, whereas in the robotic group, 1 (2%) patient experienced pleural recurrence 32 months after the initial operation. This difference was not statistically significant (P = 1.00). However, the median duration of the follow-up was significantly different between the 2 groups (P < 0.001), with a median length of 90.7 months (IQR 46.8-149.5 months) in the median sternotomy group, compared to a median length of 30.9 months (IQR 8.5-67.8 months) in the other. During follow-up, 27 patients died in the TST group, all but 1 of non-thymoma-related causes, whereas there was only 1 death in the RATS group because of leukaemia. The 5-year survival rate was 98% vs 95% (P = 0.10) for robotic vs trans-sternal, respectively (Fig. 1) .
After propensity score matching, 41 patients from the TST group were compared with 41 patients from the RATS group. Patient baseline characteristics and pathological data were similar in the 2 groups, except for tumour dimension (Table 1 ). There were no statistically significant differences between the 2 groups in terms of operative time, intraoperative blood losses and postoperative complications (Table 2) . RATS, however, still showed a significantly shorter duration of hospital stay (P = 0.04). Follow-up duration was confirmed to be longer for the TST group (median = 88.3 vs 28.3 months, P = 0.04) with no difference in terms of recurrence rate.
DISCUSSION
Thymectomy is the cornerstone in the treatment of early-stage thymoma. Different approaches have been described to perform this operation, either open or minimally invasive approaches. TST is still considered to be the gold standard due to its technical advantages and the plentiful literature confirming the superiority of oncological results. As in other surgical fields, minimally invasive techniques for performing thymectomy have gained attention in recent years for their capability to assure the complete removal of the tumour, without the disadvantages of the open techniques. Nevertheless, surgical and oncological issues are still matter of debate.
In the present study, we compared TST with RATS, both from the surgical and oncological point of view, using a propensity score matching to make the 2 populations comparable.
From the surgical point of view, minimally invasive thymectomy, particularly through the VATS approach, has always been considered a challenging operation requiring a long learning curve to perform this operation safely. Nevertheless, several groups have published their experiences, demonstrating good surgical results after robotic/thoracoscopic thymoma resection and, when compared to open approaches, significantly less blood loss and shorter postoperative stay in the minimally invasive group [4, [13] [14] [15] [16] [17] .
Only a few authors have compared TST with RATS [15, [18] [19] [20] [21] . Cakar et al. [18] published the 1st series comparing RATS with TST, showing a better clinical outcome with a lower rate of complications and reduced postoperative stay in the robotic group. Balduyck et al. [19] compared the 2 approaches using quality-oflife assessment questionnaires showing a better postoperative recovery in patients who underwent robotic surgery. Other authors corroborated the previous findings, describing a reduced blood loss and hospital stay in robotic compared to trans-sternal series [15, [20] [21] . Nonetheless, in these studies, the population was heterogeneous (patients with thymoma and/or MG, various stages of disease), and the analysis focused only on surgical aspects. On the contrary, in this study, we restricted the analysis only on early-stage thymoma, excluding Stage III tumours because, although technically feasible through the robotic approach, the resection of adjacent structures should still be considered experimental. Moreover, in comparison with an open approach, such as trans-sternal technique, it could represent a potential bias in terms of both surgical results and oncological outcome.
Our data confirm all the benefits of a minimally invasive procedure previously described. First, reduced blood loss with the robotic approach, and only 3 patients presented an intraoperative blood loss of >50 ml. Regarding the postoperative complications, the number of patients that experienced at least 1 complication was also lower in the robotic group (4% vs 15%), with a total of only 2 complications represented by a case of myasthenic crisis and a case of haemothorax.
Additionally, the day of drain removal occurred earlier with consequently shorter lengths of hospital stay. With just 3 incisions in the 3rd and 5th intercostal spaces in addition to a lower complication rate, it was possible to discharge the patients earlier without significant pain. Although a specific quality-of-life assessment has not been performed, these findings corroborated the results published by Balduyck et al. [19] , showing a better postoperative recovery in patients who underwent robotic surgery.
When comparing open and minimally invasive techniques, one of the main issues is the prolonged operative time of the latter. The skin-to-skin time of a RATS in the current series had a median duration of 132.5 min, which is about 20 min longer than the median time for a TST. There can be different explanations for this finding: firstly, in our analysis, the docking time was included in the total account of the time. As shown by Bodner et al. [6] , there are important differences when evaluating the time for the setting up of the robot, for the surgeon working at the console and the skin-to-skin time. Indeed, the long time for the robot set-up represents a bias when comparing the robotic approach with the standard sternotomy, making it difficult to compare the 2 techniques. In addition, this bias can be determined by the steep learning curve of the robotic technique and, therefore, it is inversely proportional to the surgeon's experience. Indeed, different authors have found a reduction of the operative time with an increasing number of operations performed [21, 22] .
Nevertheless, several surgeons have been reluctant to use these surgical approaches for thymoma because of the possible oncological concerns related to rupture of the capsule with implantation of the tumour during endoscopic manipulations and the supposed increased risk of local recurrence (due to reduced safety margins after minimally invasive resection). Furthermore, the lack of long-term oncological results (the longest mean follow-up is 62 months as reported by Liu et al. [23] ) and the relative rarity of these tumours are additional reasons that slowed down the spread of thoracoscopic resection for early-stage thymomas [3] [4] [5] .
Recently, Friedant et al. [17] performed a systematic review and meta-analysis of the current literature regarding minimally invasive (VATS and robotic) versus open thymectomy for thymic malignancies. Data showed no significant differences in the R0 resection rate and loco-regional recurrence in patients with Masaoka Stages I and II tumours in the 2 groups.
In the current series, only 2 patients presented a pleural recurrence in the trans-sternal group and 1 patient in the robotic group, 32 months after the initial surgery. The recurrence rate in the 2 groups showed no statistically significant differences, and the results were confirmed also after matching; however, this result might represent a false negative (or type II error), given the fact there was only 1 event. Moreover, thymomas are low-grade tumours with an indolent clinical course and late recurrences (>60 months as reported by Kimura et al. [24] ); therefore, a follow-up of at least 10 years is required. Nevertheless, with a median follow-up time of 30 months and the longest duration of the follow-up of 180 months, we can state that the RATS also appears to be safe in the mid-term follow-up from an oncological point of view.
Another important issue is the dimension of the tumour. The size of thymoma appropriate for robotic resection is still a matter of debate. The majority of the literature deals with lesions <5 cm [5, 14] . Although a large tumour size may not be considered an absolute contraindication, it may interfere with the thoracoscopic procedure, causing the manipulation to be more difficult with increased chance of an open conversion, or it may prolong the operative time [14] . On the contrary, trans-sternal operation has no dimensional limitation. Indeed, in the current series, the mean diameter of thymomas in patients operated through a robotic approach was 43.25 ± 18.43 mm, which was significantly lower than the diameter of thymomas of the other group (76.17 ± 31.82 mm, P < 0.001). Because of this, tumor dimension might represent an important bias when comparing the two techniques. However, after matching the patients also for the tumor dimension, there were no significant differences in the final result with only blood losses losing significance. On the contrary, the reduction in terms of hospital stay and the oncological outcomes were confirmed.
Finally, one of the main criticisms directed at robotic surgery is the high cost. To date, no author performed a direct cost comparison of the 2 techniques. Augustin et al. [25] performed an evaluation of the procedural costs for a RATS compared with the standard VATS approach, showing that the robotic approach was 91% more expensive than its counterpart.
The cost for the DaVinci robot is variable between 1 000 000e and 2 500 000e. In addition to this, the average costs for the annual maintenance are around 100 000e/175 000e. However, these fee could be divided among the different surgical units other than the thoracic surgical unit that use the robotic system, such as urology and gynaecology: this 'shared' use of the DaVinci robot allows for the division of the initial and running costs. Apart from the initial cost of the DaVinci system, the extra costs are mainly related to disposables. Performing a RATS requires an additional cost of about 1223e, compared to a median sternotomy. This amount was calculated by deducting the price of the stainless steel wires needed for the closure of the sternotomy (150e) from the price of the surgical robotic instruments (1373e) that are necessary for the intervention. Because the other costs of the operation (e.g. for the healthcare personal or for the anaesthesia) could be considered equal, we did not take them into consideration. However, an accurate cost analysis cannot be restricted just to the expense for the operation. In fact, another important element that should be taken into consideration is the duration of the hospitalization. According to the data of the Italian Ministry of Economy, the average daily cost for a hospital stay in Italy is around 674e. This amount is calculated taking into consideration the following elements: healthcare personal costs, board and lodging costs, drugs costs and non-healthcare personal costs. Because the RATS with the DaVinci system permits a reduced hospital stay, a significant saving is possible. With a median hospital stay of 3 days, the hospitalization is 3 days shorter than the recovery needed after a TST, with a reduced expense of 2022e per patient. Moreover, the indirect costs of the operation should also be considered. These can be defined as the lack of productivity due to the disease, which can affect the patient but also the relatives. The thymectomy performed with the DaVinci system allows for a faster recovery, with reduced postoperative pain and disabilities.
Limitations
The present study has some limitations, in particular the low number of patients, the non-randomized and retrospective fashion. In addition, the follow-up is still inadequate in allowing for a definitive conclusion regarding the oncological outcome.
Anyway, the propensity score matching enabled us to overcome some intrinsic bias and make the 2 populations more comparable, confirming the encouraging results of the robotic technique especially from a surgical point of view.
CONCLUSION
In conclusion, although the 'pure' operation cost for a RATS is sensibly higher than that for conventional sternotomy, this expense is compensated by a reduced postoperative hospital stay and a faster recovery.
